Susan Hasty, Publisher
Table of Contents . . . July 24th, 1995Non-Subscriber - Summaries Only
Somatic Transgenesis - sCD4 Is a Convenient Model for In Vivo Delivery of Soluble Proteins
Cancer Vaccines - Human Carcinoembryonic Antigen as Second-Generation Immunotherapy
Immunological Research - Eliminating Factors Necessary for Tumor Growth Stimulates Rejection
Immunological Research - Process Provides Ability to Screen Cancer Patients for Anti-Tumor Antibodies
Industry News/Diagnostics - European Launch of "Genetic DNA Probe" Announced
Industry News/Diagnostics - Proposal Selected by NIST To Develop Real-Time Micro PCR Systems
Industry News/IL-2 Gene - Gene Licensed for Treatment of Cancer
Industry News/Joint Venture - Research Collaboration Extended For Human Monoclonal Antibodies
Industry News/Patents and Technology - Allowances Received for SCID Mouse Technology
Malignant Mesothelioma - Gene Therapy May Be Effective Against Cancer That Affects Lungs
Therapy/Cord Blood - Stem Cells Show Promise for Both Transplantation and Gene Therapy
Vectors - Gene Therapy - "Fate of AAV Vector DNA After In Vivo Gene Transfer to Primate Bronchial Epithelium."
Immunology - "Suppression of Tumorigenesis by Transcription Units Expressing the Antisense E6 and E7 mRNA for the Transforming Proteins of the HPV 18 and the Sense mRNA for the Retinoblastoma (Rb) Gene in Cervical Carcinoma Cells. DOU
Antisense Technology - "Regulation of Vascular Smooth Muscle Cell Insulin-Like Growth Factor I Receptors by Phosphorothioate Oligonucleotides - Effects on Cell Growth and Evidence that Sense Targeting at the ATG Site Increases Receptor Expression.
Cancer Gene Therapy - "Chemotherapy Resistance to Taxol in Clonogenic Progenitor Cells Following Transduction of CD34 Selected Marrow and Peripheral Blood Cells with a Retrovirus That Contains the MDR-1 Chemotherapy Resistance Gene."
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.